UPLIZNA recently launched as the first FDA-approved therapy for IgG4-related disease, and we're now on track for a December 14th PDUFA date in generalized myasthenia gravis. And inflammation ...

Imaavy is the first FcRn blocker approved for anti-AChR and anti-MuSK antibody positive patients with generalized myasthenia gravis. The Food and Drug Administration (FDA) has approved Imaavy ...

Earlier this year, nipocalimab data from Vivacity-MG3 supported the medication's long-term use in generalized myasthenia gravis when it is added to standard-of-care therapies. In particular ...

Antozzi C, Vu T, Ramchandren S, et al. Long-term safety and efficacy of nipocalimab in generalized myasthenia gravis: Vivacity-MG3 open-label extension phase results. Neurology. 2025;104(7 suppl 1 ...

Highlights in myasthenia gravis (MG) from the American Academy of Neurology 2025 Annual Meeting include new therapy trials and practice reviews, as discussed by Dr Nicholas Silvestri of the ...

The two-part finale of "The Voice" Season 27 airs May 19 and 20. The top 5 contestants, representing teams Adam Levine, John Legend, Michael Bublé, and Kelsea Ballerini, will compete. Viewers can ...

and create a characteristic “nasal” voice quality. Their presence also increases vulnerability to sinus infections by blocking normal drainage pathways. The underlying cause of polyp formation ...

The Ministry of Food and Drug Safety noted on the 24th that it will approve the use of the systemic Myasthenia Gravis treatment, Listigoju (Rozanolixizumab). Myasthenia Gravis is a rare disease ...

Nasal decongestant sprays are a popular remedy for relieving nasal congestion caused by colds, allergies and sinus infections. These sprays provide quick relief allowing for easier breathing.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Imaavy plus standard of care led to improvements at ...

It began suddenly in 2010, when secondary-school teacher Alina Ali inexplicably began feeling fatigued, her voice growing hoarse ... was diagnosed with myasthenia gravis (MG), a rare autoimmune ...

The US Food and Drug Administration (FDA) has approved nipocalimab-aahu (Imaavy, Johnson & Johnson) for the treatment of generalized myasthenia gravis (gMG) in adults and adolescents 12 years of ...